- Poster presentation
- Open Access
Rapid-2-rapid – a collaborative approach to linkage for those recently infected
© Martin et al; licensee BioMed Central Ltd. 2014
- Published: 23 May 2014
- Medical Facility
- Patient Navigator
- Orthogonal Test
- Orthogonal Process
- Screening Facility
In light of evolving, 4th generation HIV diagnostics, more effective strategies to test, link, and retain clients in care, are needed. In New Jersey, USA medical facilities are twice as effective at engaging clients into HIV care as alternative screening entities including community based and public health screening facilities. The goal: Complete screening, confirmation, linkage and entry into care within 2 business days.
A facilitated, collaborative process that allows rapid engagement and treatment for all including those at highest risk of infecting others has been developed. Seven collaborations have been established across the State of NJ to connect HIV screening facilities with medical partners. Entry into care is facilitated by Patient Navigators. A two-test, sequential rapid test algorithm (RTA) is used to expedite initial screen confirmation and linkage into care improving the percentage of positive clients linked into care. A community-based screening site performs the first test; the collaborating medical site performs a second orthogonal test. The intake facility has credible verification and immediate justification for laboratory intake. The Patient Navigator serves as a concierge, tester, and facilitator.
To date, 165,317 ‘rapid-rapid’ tests have been performed in NJ. Data to be discussed includes performance data on the multi-facility orthogonal process, entry and linkage into care. Clients testing positive in rapid-rapid sites are characterized as: NEW POSITIVES, RE-ENGAGED clients or as ALREADY IN CARE.
Denied Chanty Care (ID)
Avg. Bus Days to Complete Linkage and Lab Intake
Appt No Show
YTD (Through November, 2012)
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.